Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 9/20 | 0.47 |
| ▸ | CA2 | P00918 | 9/20 | 0.47 |
| ▸ | CA9 | Q16790 | 8/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.47 |
| ▸ | CA7 | P43166 | 3/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.47 |
| ▸ | CA3 | P07451 | 2/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA6 | P23280 | 2/20 | 0.47 |
| ▸ | CA5A | P35218 | 2/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | FNTA | P49354 | 2/20 | 0.41 |
| ▸ | FNTB | P49356 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL378934 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| SCHEMBL4292980 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| SCHEMBL97774 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| SCHEMBL2324900 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| SCHEMBL2323499 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| Octadecyl Sulfate SCHEMBL3963774 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| SCHEMBL8425908 | 1.00 | CA1 (0.47) | CA1CA2CA9CA12CA7 | |
| Sulfuric Acid SCHEMBL8526889 | 0.98 | CA1 (0.46) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL11778710 | 0.98 | CA1 (0.46) | CA1CA2CA9CA12CA7 | |
| Oleyl Sulfate SCHEMBL430287 | 0.91 | PPARA (0.44) | EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210322359-A1 | SICKLE CELL DISEASE TREATMENT UTILIZING OMEGA-3 FATTY ACIDS | MICELLE BIOPHARMA, INC. (US) | 2021-10-21 | — | — | US | disclosed |
| US-20210324302-A1 | OMEGA-3 FATTY ACID ESTER COMPOSITIONS | MICELLE BIOPHARMA, INC. (US) | 2021-10-21 | — | — | US | disclosed |
| US-20210322360-A1 | SELF-MICELLIZING FATTY ACIDS AND FATTY ACID ESTER COMPOSITIONS AND THEIR USE IN THE TREATMENT OF DISEASE STATES | MICELLE BIOPHARMA, INC. (US) | 2021-10-21 | — | — | US | disclosed |
| US-11046909-B2 | Omega-3 fatty acid ester compositions | Omega Biopharma, Inc. (US) | 2021-06-29 | — | — | US | disclosed |
| US-10898458-B2 | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states | MICELLE BIOPHARMA, INC. (US) | 2021-01-26 | — | — | US | disclosed |
| US-10894027-B2 | Sickle cell disease treatment utilizing omega-3 fatty acids | MICELLE BIOPHARMA, INC. (US) | 2021-01-19 | — | — | US | disclosed |
| US-20200330422-A1 | Formulations for Treating and/or Preventing Disease | MICELLE BIOPHARMA, INC. (US) | 2020-10-22 | — | — | US | disclosed |
| EP-2830602-B1 | OMEGA-3 FATTY ACID ESTER COMPOSITIONS | MICELLE BIOPHARMA INC (US) | 2020-10-21 | — | — | EP | disclosed |
| US-20200093779-A1 | Sickle Cell Disease Treatment Utilizing Omega-3 Fatty Acids | MICELLE BIOPHARMA, INC. (US) | 2020-03-26 | — | — | US | disclosed |
| US-20190264134-A1 | OMEGA-3 FATTY ACID ESTER COMPOSITIONS | MICELLE BIOPHARMA, INC. (US) | 2019-08-29 | — | — | US | disclosed |
| US-20060127338-A1 | Aqueous suspensions of cross-linked silicone particles, aqueous emulsions of oil containing cross-linked silicone particles, and cosmetic raw material | DOW CORNING TORAY COMPANY, LTD. (JP) | 2006-06-15 | — | — | US | disclosed |
| EP-1541633-A1 | AQUEOUS SUSPENSION OF CROSSLINKED SILICONE PARTICLES, AQUEOUS EMULSION OF OIL CONTAINING CROSSLINKED SILICONE PARTICLES, AND COSMETIC INGREDIENTS | Dow Corning Toray Silicone Company, Ltd. (JP) | 2005-06-15 | — | — | EP | disclosed |
| US-20040147647-A1 | Polyorganosiloxane micro-emulsion composition and raw material for cosmetics | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 2004-07-29 | — | — | US | disclosed |
| US-20040138373-A1 | Polyorganosiloxane emulsion composition and a cosmetic material made therefrom | DOW TORAY CO., LTD. (JP) | 2004-07-15 | — | — | US | disclosed |
| US-20040091438-A1 | Polyorganosiloxane emulsions,process for producing the same and material for cosmetic preparation | DOW CORNING TORAY SILICONE CO. LTD. (JP) | 2004-05-13 | — | — | US | disclosed |
| EP-1406575-A2 | POLYORGANOSILOXANE MICRO-EMULSION COMPOSITION AND RAW MATERIAL FOR COSMETICS | Dow Corning Toray Silicone Co.,Ltd. Patent Department (JP) | 2004-04-14 | — | — | EP | disclosed |
| EP-1394215-A1 | POLYORGANOSILOXANE EMULSION, PROCESS FOR PRODUCING THE SAME, AND MATERIAL FOR COSMETIC PREPARATION | Dow Corning Toray Silicone Co., Ltd. (JP) | 2004-03-03 | — | — | EP | disclosed |
| EP-1381651-A1 | POLYORGANOSILOXANE EMULSION COMPOSITION AND A COSMETIC MATERIAL MADE THEREFROM | Dow Corning Toray Silicone Co.,Ltd. Patent Department (JP) | 2004-01-21 | — | — | EP | disclosed |
| WO-2002094213-A2 | POLYORGANOSILOXANE MICRO-EMULSION COMPOSITION AND RAW MATERIAL FOR COSMETICS | DOW CORNING TORAY SILICONE CO.,LTD. (JP) | 2002-11-28 | — | — | WO | disclosed |
| WO-2002088253-A1 | POLYORGANOSILOXANE EMULSION COMPOSITION AND A COSMETIC MATERIAL MADE THEREFROM | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 2002-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040091438-A1 | Polyorganosiloxane emulsions,process for producing the same and material for cosmetic preparation | CUTA, UNG, PCNA | CA1 3951/4885CA2 4091/4885CA9 3606/4885 |
| US-20060127338-A1 | Aqueous suspensions of cross-linked silicone particles, aqueous emulsions of oil containing cross-linked silicone particles, and cosmetic raw material | H1-0, CD44, H1-2 | CA1 3981/4885CA2 4355/4885CA9 4204/4885 |
| US-20040147647-A1 | Polyorganosiloxane micro-emulsion composition and raw material for cosmetics | UNG, PHOSPHO1, TPMT | CA1 3135/4885CA2 3796/4885CA9 2078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.